-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Text | Bai Yu
According to data from Mi Nei, in 2020, the sales scale of the terminal oral diabetic chemical drugs in Chinese urban physical pharmacies exceeds 6 billion yuan, and 12 of the TOP20 products have sales of more than 100 million yuan.
The 6 billion market is making waves again, and 11 oral hypoglycemic drugs approved this year
The 6 billion market is making waves again, and 11 oral hypoglycemic drugs approved this yearSales of oral diabetic drugs in physical pharmacies in cities in China in recent years (unit: 100 million yuan)
Source: Mi Nei.
In May of this year, the seventh national census showed that the population of 60 years and over was 264.
Oral diabetes chemicals approved for marketing since 2021
Source: Meinenet MED2.
Since the beginning of this year, a total of 11 oral hypoglycemic drugs have been approved for marketing.
One billion retail oral hypoglycemic drugs fall into the altar! Product TOP20 ranking changes
One billion retail oral hypoglycemic drugs fall into the altar! Product TOP20 ranking changes2020 China's urban physical pharmacies TOP20 oral diabetic chemical products (unit: 100 million yuan)
Source: Mi Nei.
Note: Sales of less than 100 million yuan will be displayed as "*"
The total market share of TOP20 products accounts for more than 80%, and the market concentration is relatively high
Top 20 brand names of metformin hydrochloride tablets in Chinese urban physical pharmacies in 2020
Source: Mi Nei.
At present, there are more than 100 manufacturers of metformin hydrochloride tablets, and competition is fierce
From the perspective of sales growth, sitagliptin-metformin tablets (II) and pioglitazone-metformin tablets (15mg/500mg) have the fastest growth rates, with strong growth rates of 54.
27 oral hypoglycemic drugs swarmed! Zhengda Tianqing, Kelun, Better.
Oral diabetes chemicals under review from 2018 to now
Source: Meinenet MED2.
Since 2018, a total of 27 oral hypoglycemic agents have submitted marketing applications for review and approval
Dapagliflozin tablets, sitagliptin and metformin sustained-release tablets, titagliptin hydrobromide tablets, miglitol orally disintegrating tablets, troxagliptin succinate tablets, metformin hydrochloride oral solution, lubiprostone capsules No generic drugs have been approved for 8 products of metformin and vildagliptin tablets (Ⅲ)
In addition, there are three new class 1 drugs, namely Jiangsu Hengrui Medicine's proline Henggligliflozin tablets, Repagliptin phosphate tablets, Chengdu Chipset Pharmaceuticals|Shenzhen Chiplets Biosciences Siglita sodium tablets
Data source: Mi Neiwang database
If there are any errors or omissions, please correct me!
Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
Original title: One billion retail oral hypoglycemic drugs fall into the "Altar"! TOP20 ranking changes, Chia Tai Tianqing, Beite.
.
.
the first imitation of the impact
